Companies Accolade
Accolade (ACCD): executive pay, fiscal 2024
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Accolade’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers20th pct.Of 17 peer CEOs
CEO pay, last three years
- $6,098,503FY2022
- $1,998,407FY2023
- $3,823,597FY2024
CEO total pay was $3,823,597 in fiscal 2024, up from $1,998,407 in fiscal 2023.
FY2024: salary $500,000 · bonus $0 · stock awards $3,320,097 · option awards $0
Executives and directors
Rajeev Singh · CEORichard Eskew · General CounselRobert Cavanaugh · PresidentStephen Barnes · CFOCindy Kent · Independent DirectorDawn Lepore · Independent DirectorElizabeth Nabel · Independent DirectorJeffrey Brodsky · Independent DirectorJeffrey Jordan · Independent DirectorPatricia Wadors · Independent DirectorPeter Klein · Lead Independent Director
Frequently asked questions
Who was the highest-paid executive at Accolade in fiscal 2024?
As disclosed, Rajeev Singh (Chief Executive Officer and Chairman of the Board) was the highest-paid executive at Accolade in fiscal 2024, with total compensation of $3,823,597.
How does Accolade's chief executive pay compare to its disclosed peer group?
As disclosed, Rajeev Singh's total compensation ranked at the 20th percentile of Accolade's disclosed peer group.
What is Accolade's CEO-to-median employee pay ratio?
As disclosed, Accolade's CEO-to-median employee pay ratio was 28:1.
How did shareholders vote on Accolade's executive compensation?
As disclosed, 98.97% of shareholders supported Accolade's executive compensation in the latest say-on-pay vote.
How much does Accolade spend in total on board compensation for fiscal 2024?
As disclosed, Accolade reported total board compensation of $1,622,826 for fiscal 2024.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Rajeev Singh | $500,000 | $0 | $3,320,097 | $0 | $0 | $0 | $3,500 | $3,823,597 |
| Chief Executive Officer and Chairman of the Board | ||||||||
| Robert Cavanaugh | 410,000 | 0 | 1,375,463 | 0 | 0 | 0 | 3,500 | 1,788,963 |
| President | ||||||||
| Stephen Barnes | 400,000 | 0 | 1,375,463 | 0 | 0 | 0 | 3,500 | 1,778,963 |
| Chief Financial Officer | ||||||||
| Richard Eskew | 350,000 | 0 | 664,030 | 0 | 0 | 0 | 3,500 | 1,017,530 |
| Executive Vice President, General Counsel, and Chief Compliance Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2024 total | FY2023 total | FY2022 total | Δ FY2023→2024 |
|---|---|---|---|---|
| Rajeev Singh | $3,823,597 | $1,998,407 | $6,098,503 | ↑ +1,825,190 |
| Robert Cavanaugh | 1,788,963 | 1,130,918 | 3,515,644 | ↑ +658,045 |
| Stephen Barnes | 1,778,963 | 1,138,456 | 2,936,536 | ↑ +640,507 |
| Richard Eskew | 1,017,530 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
Our compensation committee believes that the most effective executive compensation program is one that is designed to reward the achievement of our specific annual, long-term and strategic goals, and which aligns executives interests with those of our stockholders by rewarding performance above established goals, with the ultimate objective of improving stockholder value.
| CEO STI target (% of salary) | 100% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | FW Cook |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | True |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2024
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Richard Eskew | PSU | 2023-06-26 | 0 | 27,259 | — | 54,518 | $333,378 |
| Stephen Barnes | PSU | 2023-06-26 | 0 | 56,464 | — | 112,928 | 690,555 |
| Rajeev Singh | RSU | 2023-06-27 | — | — | 136,293 | — | 1,653,234 |
| Robert Cavanaugh | RSU | 2023-06-27 | — | — | 56,464 | — | 684,908 |
| Rajeev Singh | PSU | 2023-06-26 | 0 | 136,293 | — | 272,586 | 1,666,863 |
| Robert Cavanaugh | PSU | 2023-06-26 | 0 | 56,464 | — | 112,928 | 690,555 |
| Stephen Barnes | RSU | 2023-06-27 | — | — | 56,464 | — | 684,908 |
| Richard Eskew | RSU | 2023-06-27 | — | — | 27,259 | — | 330,652 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Richard Eskew | $330,652 | $333,378 | $0 | 50.2% |
| Stephen Barnes | 684,908 | 690,555 | 0 | 50.2% |
| Rajeev Singh | 1,653,234 | 1,666,863 | 0 | 50.2% |
| Robert Cavanaugh | 684,908 | 690,555 | 0 | 50.2% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2024
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Richard Eskew | Option | 2,338 | 17.5 | — |
| Richard Eskew | Option | 3,334 | 6.27 | — |
| Richard Eskew | Option | 4,147 | 53.38 | — |
| Richard Eskew | RSU | 5,000 | — | 51,250 |
| Richard Eskew | RSU | 6,220 | — | 63,755 |
| Stephen Barnes | RSU | 6,634 | — | 67,999 |
| Robert Cavanaugh | RSU | 8,160 | — | 83,640 |
| Stephen Barnes | Option | 8,334 | 17.5 | — |
| Robert Cavanaugh | Option | 8,334 | 17.5 | — |
| Stephen Barnes | Option | 8,500 | 4.7 | — |
| Robert Cavanaugh | Option | 8,500 | 4.7 | — |
| Richard Eskew | Option | 10,250 | 4.2 | — |
| Robert Cavanaugh | RSU | 11,368 | — | 116,522 |
| Richard Eskew | Option | 12,000 | 9.6 | — |
| Stephen Barnes | RSU | 12,321 | — | 126,290 |
| Rajeev Singh | Option | 12,500 | 17.5 | — |
| Stephen Barnes | Option | 13,268 | 53.38 | — |
| Rajeev Singh | RSU | 14,926 | — | 152,992 |
| Stephen Barnes | Option | 15,000 | 4.2 | — |
| Robert Cavanaugh | Option | 15,000 | 4.2 | — |
| Robert Cavanaugh | Option | 16,320 | 53.38 | — |
| Rajeev Singh | Option | 18,125 | 4.5 | — |
| Richard Eskew | Option | 20,000 | 4.7 | — |
| Richard Eskew | Option | 20,000 | 6.55 | — |
| Robert Cavanaugh | Option | 23,079 | 8.03 | — |
| Stephen Barnes | Option | 25,015 | 8.03 | — |
| Rajeev Singh | RSU | 26,401 | — | 270,610 |
| Richard Eskew | RSU | 27,259 | — | 279,405 |
| Rajeev Singh | Option | 29,851 | 53.38 | — |
| Rajeev Singh | Option | 53,601 | 8.03 | — |
| Stephen Barnes | RSU | 56,464 | — | 578,756 |
| Robert Cavanaugh | RSU | 56,464 | — | 578,756 |
| Stephen Barnes | Option | 78,000 | 4.2 | — |
| Stephen Barnes | Option | 135,000 | 9.6 | — |
| Rajeev Singh | RSU | 136,293 | — | 1,397,003 |
| Rajeev Singh | Option | 155,346 | 17.5 | — |
| Robert Cavanaugh | Option | 200,000 | 9.6 | — |
| Rajeev Singh | Option | 504,469 | 9.6 | — |
| Robert Cavanaugh | Option | 564,750 | 4.2 | — |
| Rajeev Singh | Option | 904,809 | 4.2 | — |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Peter KleinIndependent · Lead Independent Director · Audit (Chair) | $131,800 | $130,200 | $0 | $0 | $0 | $262,000 |
| Dawn LeporeIndependent · Audit · Nominating and Corporate Governance (Chair) | 106,800 | 130,200 | 0 | 0 | 0 | 237,000 |
| Elizabeth NabelIndependent · Audit | 96,800 | 130,200 | 0 | 0 | 0 | 227,000 |
| Jeffrey BrodskyIndependent · Compensation (Chair) | 96,213 | 130,200 | 0 | 0 | 0 | 226,413 |
| Patricia WadorsIndependent · Audit · Compensation | 96,213 | 130,200 | 0 | 0 | 0 | 226,413 |
| Jeffrey JordanIndependent · Compensation | 91,800 | 130,200 | 0 | 0 | 0 | 222,000 |
| Cindy KentIndependent · Nominating and Corporate Governance | 91,800 | 130,200 | 0 | 0 | 0 | 222,000 |
| Michael HiltonIndependent · Executive | 0 | 0 | 0 | 0 | 0 | 0 |
| Rajeev SinghEmployee director · Board Chair | 0 | 0 | 0 | — | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $86,800 |
|---|---|
| Annual equity retainer | $130,200 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 10,000 / 10,000 |
| Stock ownership guideline | 5x annual cash retainer ($434,000) |
Total cost of the board
| Component | FY2024 |
|---|---|
| Cash retainers and fees | $711,426 |
| Equity awards (grant-date value) | $911,400 |
| All other compensation | $0 |
| Total cost of the board | $1,622,826 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Accolade as a peer
Companies that benchmark against ACCD
10 companies name ACCD as a compensation peer
- American Well CorpAMWLFY2025
- Certara, Inc.CERTFY2025
- Chrome Holding Co.MEFY2024
- DocGo Inc.DCGOFY2025
- eHealth, Inc.EHTHFY2025
- Health Catalyst, Inc.HCATFY2025
- Privia Health Group, Inc.PRVAFY2025
- SelectQuote, Inc.SLQTFY2025
- TruBridge, Inc.CPSIFY2024
Each company listed discloses ACCD in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named ACCD in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2024
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
NXGN NextGen HealthcareAGTI AgilitiTRHC Tabula Rasa HealthCareMODN Model NSHCR Sharecare Computer Programs and SystemsAMWL American WellHSTM HealthStreamHQY HealthEquityGDRX GoodRx HoldingsHCAT Health CatalystNRC NRC HealthYEXT YextAPPF AppFolioPHR PhreesiaHIMS Hims & Hers HealthPGNY Progyny
Peer reciprocity
Of the companies Accolade names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
— NextGen Healthcare (NXGN)244 Agiliti (AGTI)✓ Tabula Rasa HealthCare (TRHC)245— Model N (MODN)246— Sharecare (SHCR)247✓ American Well (AMWL)248 HealthStream (HSTM)— HealthEquity (HQY)249— GoodRx Holdings (GDRX)250✓ Health Catalyst (HCAT)251 NRC Health (NRC)— Yext (YEXT)252 AppFolio (APPF)— Phreesia (PHR)253 Hims & Hers Health (HIMS)— Progyny (PGNY)254
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including Accolade.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | GoodRx Holdings | 2025 | Wendy Barnes | $825,000 | $10,921,182 | $9,000,000 | $0 | $23,367,483 |
| 2 | Hims & Hers Health | 2025 | Andrew Dudum | 494,792 | 10,635,352 | 11,000,000 | 585,763 | 22,958,907 |
| 3 | HealthEquity | 2026 | Scott Cutler | 775,000 | 12,038,563 | 0 | 767,250 | 13,582,105 |
| 4 | NRC Health | 2025 | Trent Green | 697,115 | 6,755,000 | 0 | 0 | 11,961,900 |
| 5 | Yext | 2026 | Michael Walrath | 482,308 | 7,675,000 | 0 | 503,608 | 8,693,973 |
| 6 | Phreesia | 2026 | Chaim Indig | 515,000 | 7,562,706 | 0 | 0 | 8,077,706 |
| 7 | NextGen Healthcare | 2023 | David Sides | 709,009 | 6,598,170 | 0 | 548,766 | 7,895,821 |
| 8 | Progyny | 2025 | Peter Anevski | 870,000 | 3,499,980 | 2,099,995 | 736,890 | 7,220,612 |
| 9 | Model N | 2023 | Jason Blessing | 556,500 | 6,009,632 | 0 | 306,628 | 6,877,671 |
| 10 | AppFolio | 2025 | Shane Trigg | 550,000 | 4,000,307 | 0 | 814,000 | 5,438,904 |
| 11 | American Well | 2025 | Ido Schoenberg | 701,755 | 1,294,331 | 0 | 2,010,100 | 4,162,171 |
| 12 | Health Catalyst | 2025 | Daniel Burton | 525,000 | 3,444,040 | 0 | 0 | 3,991,159 |
| 13 | Accolade | 2024 | Rajeev Singh | 500,000 | 3,320,097 | 0 | 0 | 3,823,597 |
| 14 | Tabula Rasa HealthCare | 2022 | Brian Adams | 450,000 | 1,633,498 | 0 | 190,688 | 2,301,712 |
| 15 | HealthStream | 2025 | Robert Frist | 400,500 | 224,977 | 79,550 | 158,100 | 868,037 |
| — | Agiliti | — | — | — | — | — | — | not in coverage universe |
| — | Sharecare | — | — | — | — | — | — | not in coverage universe |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Accolade | not disclosed | PSU 50 · RSU 50 | No | FW Cook |
| Agiliti | not disclosed | not disclosed | not disclosed | not disclosed |
| American Well | not disclosed | PSU 45 · Cash LTI 45 · RSU 10 | No | Aon |
| AppFolio | 148% | PSU 60 · RSU 40 | No | not disclosed |
| GoodRx Holdings | not disclosed | not disclosed | not disclosed | Pay Governance |
| Health Catalyst | 39% | RSU 50 · PRSU 50 | Yes — TSR Achievement | Aon |
| HealthEquity | 99% | PSU 60 · RSU 40 | Yes | Semler Brossy |
| HealthStream | 97.6% | not disclosed | No | not disclosed |
| Hims & Hers Health | 93.72% | Options 51 · RSU 49 | No | Compensia, Inc. |
| Model N | 55.1% | RSU 50 · PRSU 50 | No | Compensia |
| NextGen Healthcare | not disclosed | PSU 60 · RSU 40 | not disclosed | Frederic W. Cook & Co., Inc. |
| NRC Health | not disclosed | not disclosed | not disclosed | not disclosed |
| Phreesia | 140.3% | PSU 50 · RSU 50 | Yes — Relative TSR | FW Cook, Inc. |
| Progyny | 85% | RSU 40 · Options 30 · PSU 30 | No | Semler Brossy |
| Sharecare | 47% | RSU 75 · PSU 25 | No | not disclosed |
| Tabula Rasa HealthCare | not disclosed | PSU 50 · RSU 50 | not disclosed | Pearl Meyer & Partners, LLC |
| Yext | not disclosed | not disclosed | not disclosed | Compensia |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2024 | 2024-08-06 | 58,197,240 | 605,301 | 97,355 | 98.97% | Passed |
| 2023 | 2023-08-08 | 56,333,271 | 500,742 | 33,508 | 99.12% | Passed |
| 2022 | 2022-07-26 | 18,699,525 | 21,202,835 | 24,715 | 46.86% | Failed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2024 | 2024-08-06 | 98.97%a |
| 2023 | 2023-08-08 | 99.12%b |
| 2022 | 2022-07-26 | 46.86%c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Voting standard not stated in the filing.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 28 : 1 |
|---|---|
| CEO total compensation | $1,998,407 |
| Median employee compensation | $72,286 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2024 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Stephen Barnes | Chief Financial Officer | 2025-01-17 | A | 78,000 | $4 | $327,600 | Common | Form 4 ↗ |
| Cindy Kent | Director | 2025-01-30 | D | 1,406 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cindy Kent | Director | 2025-01-30 | A | 1,406 | 0 | 0 | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-02-03 | D | 1,568 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-02-03 | D | 757 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-02-03 | D | 1,568 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-02-03 | D | 389 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-02-03 | A | 757 | 0 | 0 | Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-02-03 | A | 389 | 0 | 0 | Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-02-03 | D | 3,786 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-02-03 | A | 3,786 | 0 | 0 | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-02-03 | A | 1,568 | 0 | 0 | Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-02-03 | A | 1,568 | 0 | 0 | Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-02-04 | D | 448 | 7 | 3,103 | Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-02-04 | D | 390 | 7 | 2,701 | Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-02-04 | D | 1,170 | 7 | 8,103 | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-02-04 | D | 557 | 7 | 3,858 | Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-02-10 | A | 770 | 0 | 0 | Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-02-10 | D | 770 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-02-10 | D | 711 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-02-10 | A | 711 | 0 | 0 | Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-02-10 | D | 1,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-02-10 | A | 1,650 | 0 | 0 | Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-02-11 | D | 221 | 7 | 1,522 | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-02-11 | D | 252 | 7 | 1,735 | Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-02-11 | D | 509 | 7 | 3,504 | Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-02-18 | D | 933 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-02-18 | A | 933 | 0 | 0 | Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-02-18 | D | 414 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-02-18 | A | 414 | 0 | 0 | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-02-18 | D | 510 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-02-18 | A | 510 | 0 | 0 | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-02-19 | D | 180 | 7 | 1,242 | Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-02-19 | D | 279 | 7 | 1,925 | Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-02-19 | D | 137 | 7 | 945 | Common | Form 4 ↗ |
| Jeffrey Brodsky | Director | 2025-02-28 | A | 2,178 | 0 | 0 | Common | Form 4 ↗ |
| Elizabeth Nabel | Director | 2025-02-28 | D | 2,178 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Elizabeth Nabel | Director | 2025-02-28 | A | 2,178 | 0 | 0 | Common | Form 4 ↗ |
| Jeffrey Brodsky | Director | 2025-02-28 | D | 2,178 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-03-03 | A | 388 | 0 | 0 | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-03-03 | D | 1,569 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-03-03 | D | 1,569 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-03-03 | D | 388 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-03-03 | A | 3,786 | 0 | 0 | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-03-03 | A | 1,569 | 0 | 0 | Common | Form 4 ↗ |
| Michael Hilton | Director | 2025-03-03 | A | 12,489 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Elizabeth Nabel | Director | 2025-03-03 | A | 12,489 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeffrey Brodsky | Director | 2025-03-03 | A | 6,245 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-03-03 | A | 757 | 0 | 0 | Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-03-03 | D | 3,786 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-03-03 | A | 1,569 | 0 | 0 | Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-03-03 | D | 757 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-03-04 | D | 377 | 7 | 2,624 | Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-03-04 | D | 1,121 | 7 | 7,802 | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-03-04 | D | 550 | 7 | 3,828 | Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-03-04 | D | 514 | 7 | 3,577 | Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-03-10 | D | 1,650 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-03-10 | A | 1,650 | 0 | 0 | Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-03-10 | D | 770 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-03-10 | A | 770 | 0 | 0 | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-03-10 | D | 710 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-03-10 | A | 710 | 0 | 0 | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-03-11 | D | 249 | 7 | 1,734 | Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-03-11 | D | 490 | 7 | 3,413 | Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-03-11 | D | 254 | 7 | 1,769 | Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-03-17 | D | 933 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-03-17 | D | 510 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-03-17 | A | 510 | 0 | 0 | Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-03-17 | D | 415 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-03-17 | A | 415 | 0 | 0 | Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-03-17 | A | 933 | — | — | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-03-18 | D | 181 | 7 | 1,264 | Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-03-18 | D | 142 | 7 | 992 | Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-03-18 | D | 289 | 7 | 2,019 | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-03-25 | A | 2,500 | 3 | 7,900 | Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-03-25 | A | 1,703 | 3 | 5,381 | Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-03-25 | A | 639 | 3 | 2,019 | Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-01 | D | 757 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-01 | A | 389 | 0 | 0 | Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-01 | D | 3,786 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-01 | D | 1,568 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-01 | A | 1,568 | 0 | 0 | Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-01 | D | 389 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-01 | A | 757 | 0 | 0 | Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-01 | A | 3,786 | 0 | 0 | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-01 | A | 1,568 | 0 | 0 | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-01 | D | 1,568 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-02 | D | 378 | 7 | 2,643 | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-02 | D | 550 | 7 | 3,846 | Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-02 | D | 922 | 7 | 6,447 | Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-02 | D | 431 | 7 | 3,014 | Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-08 | D | 12,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | D | 89,552 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | D | 120,600 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Hilton | Director | 2025-04-08 | D | 1,452 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cindy Kent | Director | 2025-04-08 | D | 10,602 | 7 | 74,532 | Common | Form 4 ↗ |
| Jeffrey Jordan | Director | 2025-04-08 | D | 1,619,088 | 7 | 11,382,189 | Common, indirect | Form 4 ↗ |
| Jeffrey Jordan | Director | 2025-04-08 | D | 27,759 | 7 | 195,146 | Common | Form 4 ↗ |
| Dawn Lepore | Director | 2025-04-08 | D | 20,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Dawn Lepore | Director | 2025-04-08 | D | 9,196 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Dawn Lepore | Director | 2025-04-08 | D | 2,659 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cindy Kent | Director | 2025-04-08 | D | 12,654 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-08 | D | 39,801 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Hilton | Director | 2025-04-08 | D | 27,860 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-08 | D | 56,464 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Peter Klein | Director | 2025-04-08 | D | 8,600 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Hilton | Director | 2025-04-08 | D | 20,821 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Hilton | Director | 2025-04-08 | D | 195,042 | 7 | 1,371,145 | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-08 | D | 51,925 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-08 | D | 564,750 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-08 | D | 55,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-08 | D | 55,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-08 | D | 20,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-08 | D | 67,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-08 | D | 21,959 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-08 | D | 2,311 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Elizabeth Nabel | Director | 2025-04-08 | D | 35,021 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cindy Kent | Director | 2025-04-08 | D | 2,659 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Dawn Lepore | Director | 2025-04-08 | D | 14,060 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | D | 2,799 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Hilton | Director | 2025-04-08 | D | 11,166 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Hilton | Director | 2025-04-08 | D | 10,234 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Hilton | Director | 2025-04-08 | D | 145,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Hilton | Director | 2025-04-08 | D | 8,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Hilton | Director | 2025-04-08 | D | 20,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Hilton | Director | 2025-04-08 | D | 12,489 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | A | 175,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-08 | A | 55,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-08 | A | 56,464 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-08 | A | 37,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-08 | A | 27,259 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-08 | A | 67,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-08 | A | 56,464 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | A | 136,293 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Hilton | Director | 2025-04-08 | D | 50,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Hilton | Director | 2025-04-08 | D | 502,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Hilton | Director | 2025-04-08 | D | 150,946 | 7 | 1,061,150 | Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-08 | D | 48,955 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-08 | D | 13,971 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-08 | D | 100,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-08 | D | 200,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-08 | D | 8,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-08 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-08 | D | 21,959 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-08 | D | 2,133 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-08 | D | 1,531 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Robert Cavanaugh | President | 2025-04-08 | D | 222,216 | 7 | 1,562,178 | Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-08 | D | 12,438 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-08 | D | 8,777 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-08 | D | 28,050 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-08 | D | 20,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-08 | D | 20,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-08 | D | 10,250 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-08 | D | 37,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-08 | D | 27,259 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-08 | D | 37,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-08 | D | 10,602 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-08 | D | 778 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Richard Eskew | EVP General Counsel | 2025-04-08 | D | 66,191 | 7 | 465,323 | Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-08 | D | 56,280 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-08 | D | 10,635 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-08 | D | 100,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-08 | D | 135,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-08 | D | 8,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-08 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-08 | D | 56,464 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-08 | D | 67,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-08 | D | 1,245 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen Barnes | Chief Financial Officer | 2025-04-08 | D | 306,874 | 7 | 2,157,324 | Common | Form 4 ↗ |
| Elizabeth Nabel | Director | 2025-04-08 | D | 12,489 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Elizabeth Nabel | Director | 2025-04-08 | D | 41,982 | 7 | 295,133 | Common | Form 4 ↗ |
| Jeffrey Brodsky | Director | 2025-04-08 | D | 6,245 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeffrey Brodsky | Director | 2025-04-08 | D | 35,021 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeffrey Brodsky | Director | 2025-04-08 | D | 46,810 | 7 | 329,074 | Common | Form 4 ↗ |
| Jeffrey Jordan | Director | 2025-04-08 | D | 35,021 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeffrey Jordan | Director | 2025-04-08 | D | 3,779,620 | 7 | 26,570,729 | Common, indirect | Form 4 ↗ |
| Peter Klein | Director | 2025-04-08 | D | 20,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Peter Klein | Director | 2025-04-08 | D | 35,021 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Peter Klein | Director | 2025-04-08 | D | 28,329 | 7 | 199,153 | Common | Form 4 ↗ |
| Patricia Wadors | Director | 2025-04-08 | D | 20,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Patricia Wadors | Director | 2025-04-08 | D | 35,021 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Patricia Wadors | Director | 2025-04-08 | D | 27,759 | 7 | 195,146 | Common | Form 4 ↗ |
| Cindy Kent | Director | 2025-04-08 | D | 35,021 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Cindy Kent | Director | 2025-04-08 | D | 1,360 | 7 | 9,561 | Common | Form 4 ↗ |
| Dawn Lepore | Director | 2025-04-08 | D | 8,600 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Dawn Lepore | Director | 2025-04-08 | D | 35,021 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Dawn Lepore | Director | 2025-04-08 | D | 922 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | D | 17,846 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | D | 150,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | D | 504,469 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | D | 12,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | D | 18,125 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | D | 904,809 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | D | 175,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | D | 136,293 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | D | 175,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | D | 53,004 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | D | 4,951 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | D | 651,619 | 7 | 4,580,882 | Common | Form 4 ↗ |
| Rajeev Singh | Director | 2025-04-08 | D | 831,955 | 7 | 5,848,644 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (254 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Rajeev Singh. DEF 14A, filed 2024-06-21. Section “SUMMARY COMPENSATION TABLE” · page 30. As printed: 3,823,597. View filing ↗
- Section 01, Robert Cavanaugh. DEF 14A, filed 2024-06-21. Section “SUMMARY COMPENSATION TABLE”. As printed: 1,788,963. View filing ↗
- Section 01, Stephen Barnes. DEF 14A, filed 2024-06-21. Section “SUMMARY COMPENSATION TABLE”. As printed: 1,778,963. View filing ↗
- Section 01, Richard Eskew. DEF 14A, filed 2024-06-21. Section “SUMMARY COMPENSATION TABLE”. As printed: 1,017,530. View filing ↗
- Section 03, Richard Eskew PSU. DEF 14A, filed 2024-06-21. Section “SUMMARY COMPENSATION TABLE” · grants of plan-based awards table. View filing ↗
- Section 03, Stephen Barnes PSU. DEF 14A, filed 2024-06-21. Section “SUMMARY COMPENSATION TABLE” · grants of plan-based awards table. View filing ↗
- Section 03, Rajeev Singh RSU. DEF 14A, filed 2024-06-21. Section “SUMMARY COMPENSATION TABLE” · grants of plan-based awards table. View filing ↗
- Section 03, Robert Cavanaugh RSU. DEF 14A, filed 2024-06-21. Section “SUMMARY COMPENSATION TABLE” · grants of plan-based awards table. View filing ↗
- Section 03, Rajeev Singh PSU. DEF 14A, filed 2024-06-21. Section “SUMMARY COMPENSATION TABLE” · grants of plan-based awards table. View filing ↗
- Section 03, Robert Cavanaugh PSU. DEF 14A, filed 2024-06-21. Section “SUMMARY COMPENSATION TABLE” · grants of plan-based awards table. View filing ↗
- Section 03, Stephen Barnes RSU. DEF 14A, filed 2024-06-21. Section “SUMMARY COMPENSATION TABLE” · grants of plan-based awards table. View filing ↗
- Section 03, Richard Eskew RSU. DEF 14A, filed 2024-06-21. Section “SUMMARY COMPENSATION TABLE” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2023-06-27. Section “CEO Pay Ratio”. As printed: 28 : 1. View filing ↗
- Section 08, Peter Klein. DEF 14A, filed 2024-06-21. Section “Director Compensation”. As printed: 262,000. View filing ↗
- Section 08, Dawn Lepore. DEF 14A, filed 2024-06-21. Section “Director Compensation”. As printed: 237,000. View filing ↗
- Section 08, Elizabeth Nabel. DEF 14A, filed 2024-06-21. Section “Director Compensation”. As printed: 227,000. View filing ↗
- Section 08, Jeffrey Brodsky. DEF 14A, filed 2024-06-21. Section “Director Compensation”. As printed: 226,413. View filing ↗
- Section 08, Patricia Wadors. DEF 14A, filed 2024-06-21. Section “Director Compensation”. As printed: 226,413. View filing ↗
- Section 08, Jeffrey Jordan. DEF 14A, filed 2024-06-21. Section “Director Compensation”. As printed: 222,000. View filing ↗
- Section 08, Cindy Kent. DEF 14A, filed 2024-06-21. Section “Director Compensation”. As printed: 222,000. View filing ↗
- Section 08, Michael Hilton. DEF 14A, filed 2024-06-21. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Rajeev Singh. DEF 14A, filed 2024-06-21. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, Stephen Barnes 2025-01-17. Form 4, filed 2025-01-22. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Cindy Kent 2025-01-30. Form 4, filed 2025-02-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Cindy Kent 2025-01-30. Form 4, filed 2025-02-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-02-03. Form 4, filed 2025-02-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-02-03. Form 4, filed 2025-02-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-02-03. Form 4, filed 2025-02-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-02-03. Form 4, filed 2025-02-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-02-03. Form 4, filed 2025-02-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-02-03. Form 4, filed 2025-02-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-02-03. Form 4, filed 2025-02-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-02-03. Form 4, filed 2025-02-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-02-03. Form 4, filed 2025-02-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-02-03. Form 4, filed 2025-02-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-02-04. Form 4, filed 2025-02-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-02-04. Form 4, filed 2025-02-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-02-04. Form 4, filed 2025-02-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-02-04. Form 4, filed 2025-02-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-02-10. Form 4, filed 2025-02-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-02-10. Form 4, filed 2025-02-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-02-10. Form 4, filed 2025-02-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-02-10. Form 4, filed 2025-02-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-02-10. Form 4, filed 2025-02-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-02-10. Form 4, filed 2025-02-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-02-11. Form 4, filed 2025-02-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-02-11. Form 4, filed 2025-02-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-02-11. Form 4, filed 2025-02-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-02-18. Form 4, filed 2025-02-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-02-18. Form 4, filed 2025-02-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-02-18. Form 4, filed 2025-02-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-02-18. Form 4, filed 2025-02-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-02-18. Form 4, filed 2025-02-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-02-18. Form 4, filed 2025-02-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-02-19. Form 4, filed 2025-02-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-02-19. Form 4, filed 2025-02-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-02-19. Form 4, filed 2025-02-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jeffrey Brodsky 2025-02-28. Form 4, filed 2025-03-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Elizabeth Nabel 2025-02-28. Form 4, filed 2025-03-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Elizabeth Nabel 2025-02-28. Form 4, filed 2025-03-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jeffrey Brodsky 2025-02-28. Form 4, filed 2025-03-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael Hilton 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Elizabeth Nabel 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jeffrey Brodsky 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-03-03. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-03-04. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-03-04. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-03-04. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-03-04. Form 4, filed 2025-03-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-03-10. Form 4, filed 2025-03-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-03-10. Form 4, filed 2025-03-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-03-10. Form 4, filed 2025-03-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-03-10. Form 4, filed 2025-03-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-03-10. Form 4, filed 2025-03-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-03-10. Form 4, filed 2025-03-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-03-11. Form 4, filed 2025-03-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-03-11. Form 4, filed 2025-03-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-03-11. Form 4, filed 2025-03-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-03-17. Form 4, filed 2025-03-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-03-17. Form 4, filed 2025-03-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-03-17. Form 4, filed 2025-03-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-03-17. Form 4, filed 2025-03-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-03-17. Form 4, filed 2025-03-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-03-17. Form 4, filed 2025-03-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-03-18. Form 4, filed 2025-03-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-03-18. Form 4, filed 2025-03-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-03-18. Form 4, filed 2025-03-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-03-25. Form 4, filed 2025-03-26. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-03-25. Form 4, filed 2025-03-26. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-03-25. Form 4, filed 2025-03-26. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-01. Form 4, filed 2025-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-01. Form 4, filed 2025-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-01. Form 4, filed 2025-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-01. Form 4, filed 2025-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-01. Form 4, filed 2025-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-01. Form 4, filed 2025-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-01. Form 4, filed 2025-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-01. Form 4, filed 2025-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-01. Form 4, filed 2025-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-01. Form 4, filed 2025-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-02. Form 4, filed 2025-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-02. Form 4, filed 2025-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-02. Form 4, filed 2025-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-02. Form 4, filed 2025-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael Hilton 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Cindy Kent 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jeffrey Jordan 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jeffrey Jordan 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dawn Lepore 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dawn Lepore 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dawn Lepore 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Cindy Kent 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael Hilton 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Peter Klein 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael Hilton 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael Hilton 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Elizabeth Nabel 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Cindy Kent 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dawn Lepore 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael Hilton 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael Hilton 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael Hilton 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael Hilton 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael Hilton 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael Hilton 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael Hilton 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael Hilton 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael Hilton 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert Cavanaugh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Eskew 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen Barnes 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Elizabeth Nabel 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Elizabeth Nabel 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jeffrey Brodsky 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jeffrey Brodsky 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jeffrey Brodsky 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jeffrey Jordan 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jeffrey Jordan 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Peter Klein 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Peter Klein 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Peter Klein 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patricia Wadors 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patricia Wadors 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patricia Wadors 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Cindy Kent 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Cindy Kent 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dawn Lepore 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dawn Lepore 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dawn Lepore 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rajeev Singh 2025-04-08. Form 4, filed 2025-04-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-08-07. Item 5.07 · say-on-pay result. As reported: 98.97% (votes for as printed: 58,197,240). View filing ↗
- Section 06, 2023 vote. Form 8-K, filed 2023-08-09. Item 5.07 · say-on-pay result. As reported: 99.12% (votes for as printed: 56,333,271). View filing ↗
- Section 06, 2022 vote. Form 8-K, filed 2022-07-28. Item 5.07 · say-on-pay result. As reported: 46.86%. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 711,426 + equity 911,400 + all other 0 = 1,622,826, summed across the director compensation table rows.
- GoodRx Holdings, Section 10b CEO total. DEF 14A, filed 2026-04-29. CEO total compensation as printed in GoodRx Holdings's own proxy. As printed: 23,367,483. View filing ↗
- Hims & Hers Health, Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Hims & Hers Health's own proxy. As printed: 22,958,907. View filing ↗
- HealthEquity, Section 10b CEO total. DEF 14A, filed 2026-05-13. CEO total compensation as printed in HealthEquity's own proxy. As printed: 13,582,105. View filing ↗
- NRC Health, Section 10b CEO total. DEF 14A, filed 2026-05-08. CEO total compensation as printed in NRC Health's own proxy. As printed: 11,961,900. View filing ↗
- Yext, Section 10b CEO total. DEF 14A, filed 2026-04-27. CEO total compensation as printed in Yext's own proxy. As printed: 8,693,973. View filing ↗
- Phreesia, Section 10b CEO total. DEF 14A, filed 2026-05-14. CEO total compensation as printed in Phreesia's own proxy. As printed: 8,077,706. View filing ↗
- NextGen Healthcare, Section 10b CEO total. DEF 14A, filed 2023-07-27. CEO total compensation as printed in NextGen Healthcare's own proxy. As printed: 7,895,821. View filing ↗
- Progyny, Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in Progyny's own proxy. As printed: 7,220,612. View filing ↗
- Model N, Section 10b CEO total. DEF 14A, filed 2024-01-05. CEO total compensation as printed in Model N's own proxy. As printed: 6,877,671. View filing ↗
- AppFolio, Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in AppFolio's own proxy. As printed: 5,438,904. View filing ↗
- American Well, Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in American Well's own proxy. As printed: 4,162,171. View filing ↗
- Health Catalyst, Section 10b CEO total. DEF 14A, filed 2026-06-03. CEO total compensation as printed in Health Catalyst's own proxy. As printed: 3,991,159. View filing ↗
- Accolade (subject), Section 10b CEO total. DEF 14A, filed 2024-06-21. CEO total compensation as printed in Accolade's own proxy. As printed: 3,823,597. View filing ↗
- Tabula Rasa HealthCare, Section 10b CEO total. DEF 14A, filed 2023-04-28. CEO total compensation as printed in Tabula Rasa HealthCare's own proxy. As printed: 2,301,712. View filing ↗
- HealthStream, Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in HealthStream's own proxy. As printed: 868,037. View filing ↗
- Section 10a, NextGen Healthcare reciprocity. DEF 14A. NextGen Healthcare's most recent proxy was read; its disclosed peer group does not include Accolade. View filing ↗
- Section 10a, Tabula Rasa HealthCare reciprocity. DEF 14A. Tabula Rasa HealthCare names Accolade in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Model N reciprocity. DEF 14A. Model N's most recent proxy was read; its disclosed peer group does not include Accolade. View filing ↗
- Section 10a, Sharecare reciprocity. DEF 14A. Sharecare's most recent proxy was read; its disclosed peer group does not include Accolade. View filing ↗
- Section 10a, American Well reciprocity. DEF 14A. American Well names Accolade in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, HealthEquity reciprocity. DEF 14A. HealthEquity's most recent proxy was read; its disclosed peer group does not include Accolade. View filing ↗
- Section 10a, GoodRx Holdings reciprocity. DEF 14A. GoodRx Holdings's most recent proxy was read; its disclosed peer group does not include Accolade. View filing ↗
- Section 10a, Health Catalyst reciprocity. DEF 14A. Health Catalyst names Accolade in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Yext reciprocity. DEF 14A. Yext's most recent proxy was read; its disclosed peer group does not include Accolade. View filing ↗
- Section 10a, Phreesia reciprocity. DEF 14A. Phreesia's most recent proxy was read; its disclosed peer group does not include Accolade. View filing ↗
- Section 10a, Progyny reciprocity. DEF 14A. Progyny's most recent proxy was read; its disclosed peer group does not include Accolade. View filing ↗